Guangyuyuan Chinese herbal medicine (600771.SH): giving company products to all shareholders and providing visit reception services.
Guangyuyuan (600771.SH) announced on June 7th that in order to facilitate shareholders' better understanding of the company and experience the company's products, the company decided to give away health products of traditional chinese medicine to all shareholders free of charge, and provide regular visits to the chinese herbal medicine cultural industry park and free visits to some national museums. The activity details are announced as follows: On June 21, 2024 (the equity registration day of the company's 2023 annual general meeting of shareholders) after the market closes at 15:00, for shareholders holding the company's shares registered at the Shanghai branch of China Securities Depository and Clearing Corporation Limited. The application time is 2024.
Guang Yu Yuan (600771.SH): Guiling Lu Liquor products do not contain sugar
Gelonghui, May 29丨Guang Yuyuan (600771.SH) said on the investor interactive platform that whether flavored Guiling Liquor or Yuanji brand Guiling Ji Health Liquor, they are produced in accordance with product prescriptions and registration approvals. Turtle Age Liquor products do not contain sugar.
Is The Market Rewarding GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
It is hard to get excited after looking at GuangYuYuan Chinese Herbal Medicine's (SHSE:600771) recent performance, when its stock has declined 7.8% over the past three months. It seems that the mark
Guangyuyuan Chinese Herbal Medicine Gets Government Grants Worth 13 Million Yuan
Guangyuyuan Chinese Herbal Medicine (SHA:600771) secured income-related government subsidies amounting to 12.8 million yuan, according to the company's disclosure published on the Shanghai Stock Excha
Guang Yuyuan (600771.SH): The subsidiary received a total of 12.7823 million yuan in government subsidies
Gelonghui, May 15, 丨 Guang Yuyuan (600771.SH) announced that since January 1, 2024, the company's relevant subsidiaries have received a total of 12.7823 million yuan in government subsidies related to revenue, accounting for 14.19% of the company's 2023 audited net profit attributable to shareholders of listed companies.
GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Business Is Yet to Catch Up With Its Share Price
When you see that almost half of the companies in the Pharmaceuticals industry in China have price-to-sales ratios (or "P/S") below 3.4x, GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) lo
Guang Yuyuan (600771.SH) announced first-quarter results, net profit of 41.3036 million yuan, a year-on-year increase of 49.61%
Guang Yuyuan (600771.SH) released its report for the first quarter of 2024, with revenue of 343 million yuan, compared with...
Guang Yuyuan (600771.SH) and related personnel received the “Administrative Penalty Decision” and the “Market Ban Decision”
Zhitong Finance App News, Guang Yuyuan (600771.SH) announced that on April 10, 2024, the company and relevant parties received the “Administrative Penalty Decision” and “Market Ban Decision” issued by the Shanxi Regulatory Bureau (“Shanxi Securities Regulatory Bureau”) of the China Securities Regulatory Commission. It was discovered that the company and related parties had the following illegal facts: the disclosure of the “buyout sales” model in the company's 2016 to 2021 annual report was untrue. In the case where the subsidiary Shanxi Guangyuyuan Sinopharm Co., Ltd. (“Shanxi Guangyuyuan”) had an agreement with some downstream commercial companies that “the product is slow to sell and has an immediate expiration date, and can be returned unconditionally”
Zhang Bin, director of Guang Yuyuan (600771.SH), and Miao Hui, director and president, resign
Guang Yuyuan (600771.SH) issued an announcement. The board of directors of the company recently received Director Zhang Bin and Director and CEO Miao Hui...
Guang Yu Yuan (600771.SH): Brand communication has been gradually carried out through promotional forms such as the title High Speed Rail
Gelonghui, April 8, 丨 Guang Yuyuan (600771.SH) said on the investor interactive platform that Guang Yuyuan, as an old Chinese traditional Chinese medicine manufacturer with a history of nearly 500 years, currently has relatively weak brand awareness and influence. The company has gradually carried out brand communication through publicity forms such as the high-speed rail title. Currently, the company plans to enhance the company's popularity and product quality image through more cultural communication channels and active participation in professional activities in the industry on the basis of comprehensive research and evaluation of input, output, and operating needs.
GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Delivers Shareholders Respectable 11% CAGR Over 3 Years, Surging 7.0% in the Last Week Alone
It hasn't been the best quarter for GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) shareholders, since the share price has fallen 13% in that time. But over three years, the returns wo
Guang Yuyuan (600771.SH): The company's production, operation and supply logistics are all normal
Gelonghui, January 12 | Guang Yuyuan (600771.SH) said on the investor interactive platform that in mid-December 2023, the company's boutique traditional Chinese medicine division suspended delivery for a few days due to the installation of a business system directly connected to supply chain data. The purpose of this move was to implement the company's digital intelligence construction work arrangements and promote the quality and efficiency of the company's and dealers' work. The company's production, operation and supply logistics are all normal.
GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Share Price Not Quite Adding Up
GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) price-to-sales (or "P/S") ratio of 11.9x may look like a poor investment opportunity when you consider close to half the companies in the
GuangYuYuan Makes Leadership Reshuffle
Yang Bo has resigned as chairman of GuangYuYuan Chinese Herbal Medicine (SHA:600771) and was named vice chairman amid a leadership reshuffle. Li Xiaojun, who previously served as vice chairman and gen
Guang Yuyuan (600771.SH) elected Li Xiaojun as chairman
Guang Yuyuan (600771.SH) issued an announcement. The company's board of directors received a written resignation report from Chairman Yang Bo today,...
600771.SH: The company has Guangyuyuan boutique stores in Chongqing and Chengdu
On December 26, Gelonghui (600771.SH) stated on the investor interactive platform on December 26 that the company has Guangyuyuan boutique stores in Chongqing and Chengdu.
Wu Han of Zhongkang Technology: The key to solving the development problems of the traditional Chinese medicine industry is to break the “island effect”
The first Traditional Chinese Medicine Ecological Conference is expected to bring new opportunities and perspectives to enterprise development and industrial upgrading.
[Instant Analysis of BT Financial Report] Guangyuyuan 2023 Third Quarter Report: Net profit turned loss into profit, net cash flow increased dramatically
This financial report was announced: 2023-10-24 16:07:51 Guangyuyuan (stock code: 600771) is a company that focuses on the production and sale of traditional Chinese medicine products and belongs to the pharmaceutical manufacturing industry. The company's core business is the proprietary Chinese medicine business, which includes three major segments: traditional Chinese medicine, fine traditional Chinese medicine, and health wine. The company has drug registration approvals, trademarks and patented technology for various dosage forms. Thirty-six drugs from its holding subsidiary, Shanxi Guangyuyuan, were included in the national essential drugs catalogue, and 62 drugs were included in the national basic medical insurance, work injury insurance, and maternity insurance drug catalogue. In terms of assets and liabilities, it has a long reputation
Guang Yu Yuan (600771.SH): Net profit of 144.23,300 yuan in the third quarter
Glonghui, Oct. 24, 丨 Guang Yu Yuan (600771.SH) announced its report for the third quarter of 2023. Operating income for the reporting period was 274 million yuan, down 19.87% from the previous year; net profit attributable to shareholders of listed companies was 144.23,300 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 2.6853 million yuan; basic earnings per share of 0.03 yuan/share.
Recent 8.5% Pullback Isn't Enough to Hurt Long-term GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Shareholders, They're Still up 74% Over 3 Years
While GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 11% in th
No Data